bucladesine and Chronic Lung Injury

bucladesine has been researched along with Chronic Lung Injury in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiang, CH; Lu, HL1
Chang, ML; Chen, HI; Hsu, K; Wang, D; Wu, CP1
Barnard, J; Haynes, J; Seibert, AF; Taylor, A; Thompson, WJ; Wilborn, WH1
Adkins, WK; Barnard, JW; Haynes, J; May, S; Seibert, AF; Taylor, AE1
Bysani, GK; Gurtner, GH; Hasty, D; Hoidal, JR; Hopkins, C; Kennedy, TP; Lazar, R; Michael, JR; Sciuto, AM; Tolley, E1

Other Studies

5 other study(ies) available for bucladesine and Chronic Lung Injury

ArticleYear
Combined therapy of pentastarch, dexamethasone, and dibutyryl-cAMP or beta 2-agonist attenuates ischaemia/reperfusion injury of rat lung.
    Injury, 2008, Volume: 39, Issue:9

    Topics: Adrenergic beta-2 Receptor Antagonists; Animals; Anti-Inflammatory Agents; Bucladesine; Cytokines; Dexamethasone; Drug Therapy, Combination; Hydroxyethyl Starch Derivatives; Lung Injury; Male; Plasma Substitutes; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Reperfusion Injury; RNA, Messenger; Vascular Resistance

2008
Pulmonary edema induced by phorbol myristate acetate is attenuated by compounds that increase intracellular cAMP.
    Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1996, Volume: 196, Issue:1

    Topics: Adrenergic beta-Agonists; Aminophylline; Animals; Blood Pressure; Bucladesine; Capillary Permeability; Cyclic AMP; Disease Models, Animal; Humans; Lung; Lung Injury; Male; Neutrophils; Phosphodiesterase Inhibitors; Pulmonary Artery; Pulmonary Edema; Rabbits; Respiratory Distress Syndrome; Terbutaline; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha

1996
Reversal of increased microvascular permeability associated with ischemia-reperfusion: role of cAMP.
    Journal of applied physiology (Bethesda, Md. : 1985), 1992, Volume: 72, Issue:1

    Topics: Animals; Bucladesine; Capillary Permeability; Colforsin; Cyclic AMP; In Vitro Techniques; Isoproterenol; Lung; Lung Injury; Male; Perfusion; Pulmonary Circulation; Rats; Reperfusion Injury

1992
Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capillary injury.
    Journal of applied physiology (Bethesda, Md. : 1985), 1992, Volume: 72, Issue:2

    Topics: Animals; Bucladesine; Capillaries; Capillary Permeability; Colforsin; Cyclic AMP; Endothelium, Vascular; In Vitro Techniques; Isoproterenol; Lung; Lung Injury; Rabbits; Reperfusion Injury; Vascular Resistance

1992
Dibutyryl cAMP, aminophylline, and beta-adrenergic agonists protect against pulmonary edema caused by phosgene.
    Journal of applied physiology (Bethesda, Md. : 1985), 1989, Volume: 67, Issue:6

    Topics: Aminophylline; Animals; Bucladesine; Isoproterenol; Lung; Lung Injury; Malondialdehyde; Phosgene; Pulmonary Edema; Rabbits; Terbutaline

1989